Hypertension health-tech firm Aktiia today announced a $17.5M Series A round of funding for its revolutionary blood pressure monitoring solution. The company’s automated blood pressure monitoring system enables stress-free reading round the clock, offering the potential to transform the diagnosis and treatment of hypertension. The new investment has been earmarked to accelerate adoption of the technology in the UK’s NHS and health systems across Europe.
Link to publication.
